EE29 Cost-Effectiveness of Niraparib Plus Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer

Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.330
https://www.valueinhealthjournal.com/article/S1098-3015(24)00445-5/fulltext
Title : EE29 Cost-Effectiveness of Niraparib Plus Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00445-5&doi=10.1016/j.jval.2024.03.330
First page :
Section Title :
Open access? : No
Section Order : 11679
Categories :
Tags :
Regions :
ViH Article Tags :